Literature DB >> 18603168

Treatment recommendations and practical applications of botulinum toxin treatment of cervical dystonia.

David Swope1, Richard Barbano.   

Abstract

CD is a complex disorder that can have significant impact on a patient's quality of life and physical well-being. BoNTs are a very effective and well-tolerated first-line therapy in relieving CD symptoms over long-term treatment. BoNT treatment should be administered at the lowest effective dose with a minimum of 3 months between treatments. As the incidence of immunoresistance is low, a reassessment of muscle selection, dosing, and diagnosis should take place in the event of suboptimal patient response. Optimal treatment may involve a combination of oral pharmacologic treatment with BoNTs to maintain the use of lowest possible dosing and to extend effectiveness to the recommended 3-month dosing interval. Physical therapy in conjunction with BoNT treatment can also extend treatment efficacy as well. Comorbidities such as insomnia, depression, and anxiety can interfere with successful CD treatment and should be actively managed along with the symptoms of CD. Although our understanding of CD is incomplete, it is ever expanding. As a deeper understanding of disease pathophysiology and disease progression is gained, treatment efforts will be refined for optimal outcome and patient satisfaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18603168     DOI: 10.1016/s0733-8619(08)80005-9

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  10 in total

1.  Bilateral subthalamic nucleus deep brain stimulation for refractory isolated cervical dystonia.

Authors:  Feng Yin; Mingming Zhao; Xin Yan; Tong Li; Hui Chen; Jianguang Li; Shouming Cao; Hui Guo; Shuang Liu
Journal:  Sci Rep       Date:  2022-05-10       Impact factor: 4.996

2.  Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.

Authors:  Olivia Samotus; Jack Lee; Mandar Jog
Journal:  J Neurol       Date:  2018-03-20       Impact factor: 4.849

Review 3.  Clinical uses of botulinum neurotoxins: current indications, limitations and future developments.

Authors:  Sheng Chen
Journal:  Toxins (Basel)       Date:  2012-10-19       Impact factor: 4.546

4.  Reduced Number of Pigmented Neurons in the Substantia Nigra of Dystonia Patients? Findings from Extensive Neuropathologic, Immunohistochemistry, and Quantitative Analyses.

Authors:  Diego Iacono; Maria Geraci-Erck; Hui Peng; Marcie L Rabin; Roger Kurlan
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-05-13

Review 5.  Pain Relief in Cervical Dystonia with Botulinum Toxin Treatment.

Authors:  Carlos Henrique Ferreira Camargo; Lígia Cattai; Hélio Afonso Ghizoni Teive
Journal:  Toxins (Basel)       Date:  2015-06-23       Impact factor: 4.546

6.  Botulinum toxin therapy for cervical dystonia: the science of dosing.

Authors:  Virgilio Gerald H Evidente; Eric J Pappert
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2014-11-12

7.  A retrospective study to assess resource utilization in patients with cervical dystonia in the United Kingdom.

Authors:  Mireia Raluy-Callado; Sylvie Gabriel; Jérôme Dinet; Meng Wang; Radek Wasiak
Journal:  Neuropsychiatr Dis Treat       Date:  2015-03-09       Impact factor: 2.570

Review 8.  Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement.

Authors:  Alberto Albanese; Giovanni Abbruzzese; Dirk Dressler; Wojciech Duzynski; Svetlana Khatkova; Maria Jose Marti; Pablo Mir; Cesare Montecucco; Elena Moro; Michaela Pinter; Maja Relja; Emmanuel Roze; Inger Marie Skogseid; Sofiya Timerbaeva; Charalampos Tzoulis
Journal:  J Neurol       Date:  2015-04-01       Impact factor: 4.849

9.  Nonlinear Changes in Botulinum Toxin Treatment of Task-Specific Dystonia during Long-Term Treatment.

Authors:  André Lee; Jabreel Al-Sarea; Eckart Altenmüller
Journal:  Toxins (Basel)       Date:  2021-05-22       Impact factor: 4.546

10.  Minor Structural Differences in the Cervical Spine Between Patients With Cervical Dystonia and Age-Matched Healthy Controls.

Authors:  Petra Katschnig-Winter; Christian Enzinger; Dennis Bohlsen; Marton Magyar; Stephan Seiler; Edith Hofer; Sebastian Franthal; Nina Homayoon; Mariella Kögl; Karoline Wenzel; Hannes Deutschmann; Franz Fazekas; Reinhold Schmidt; Petra Schwingenschuh
Journal:  Front Neurol       Date:  2020-05-29       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.